Ionis Pharmaceuticals, Inc. (IONS) compared with its closest peers (MDGL, ANIP, HRMY, ACAD, ARWR). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Madrigal Pharmaceuticals, ANI Pharmaceuticals, Harmony Biosciences, ACADIA Pharmaceuticals, Arrowhead Pharmaceuticals, Prestige Consumer Healthcare, Lakefront Biotherapeutics, Corcept Therapeutics, Emergent BioSolutions and Pacira BioSciences share Ionis Pharmaceuticals's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | $11.94B | -45.4 |
| ANI Pharmaceuticals, Inc. (ANIP) | $1.65B | 15.3 |
| Harmony Biosciences Holdings, Inc. (HRMY) | $2.22B | 12.3 |
| ACADIA Pharmaceuticals Inc. (ACAD) | $5.05B | 13.4 |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | $12.31B | -3453.0 |
| Prestige Consumer Healthcare Inc. (PBH) | $2.43B | 14.1 |
| Lakefront Biotherapeutics NV (LKFT) | $1.93B | 6.0 |
| Corcept Therapeutics Incorporated (CORT) | $13.22B | 42.5 |
| Emergent BioSolutions Inc. (EBS) | $262.37M | 2.3 |
| Pacira BioSciences, Inc. (PCRX) | $982.99M | 67.2 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
IONS overview · IONS earnings · IONS financials · IONS KPIs · IONS documents · IONS ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.